SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027823
Filing Date
2023-06-14
Accepted
2023-06-13 20:02:29
Documents
12
Period of Report
2023-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnov-20230613.htm   iXBRL 8-K 105711
  Complete submission text file 0000950170-23-027823.txt   227581

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnov-20230613_pre.xml EX-101.PRE 11447
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnov-20230613_lab.xml EX-101.LAB 14496
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnov-20230613.xsd EX-101.SCH 2470
6 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20230613_htm.xml XML 4693
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 231012689
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences